Machine Learning for Biomedicine
ML4BM
Eli Lilly and Company
Indianapolis, EE. UU.Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (2)
2013
-
Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck
European Journal of Cancer, Vol. 49, Núm. 13, pp. 2877-2883
2005
-
Assessment of the value of confirming responses in clinical trials in oncology
European Journal of Cancer, Vol. 41, Núm. 11, pp. 1528-1532